CN106036877A - Nutritional compound for improving sleep and application thereof - Google Patents
Nutritional compound for improving sleep and application thereof Download PDFInfo
- Publication number
- CN106036877A CN106036877A CN201610493354.3A CN201610493354A CN106036877A CN 106036877 A CN106036877 A CN 106036877A CN 201610493354 A CN201610493354 A CN 201610493354A CN 106036877 A CN106036877 A CN 106036877A
- Authority
- CN
- China
- Prior art keywords
- sleep
- improving sleep
- nutritional composition
- improving
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 40
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 22
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011701 zinc Substances 0.000 claims abstract description 19
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 18
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000011575 calcium Substances 0.000 claims abstract description 18
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 18
- 239000011777 magnesium Substances 0.000 claims abstract description 18
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims 3
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 23
- 241000234435 Lilium Species 0.000 abstract description 16
- 240000006079 Schisandra chinensis Species 0.000 abstract description 16
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract description 16
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract description 11
- 230000001914 calming effect Effects 0.000 abstract description 10
- 230000004060 metabolic process Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 210000003169 central nervous system Anatomy 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 3
- 206010038743 Restlessness Diseases 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000002618 waking effect Effects 0.000 abstract description 3
- 206010012335 Dependence Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000009897 systematic effect Effects 0.000 abstract description 2
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 18
- 241001247821 Ziziphus Species 0.000 description 10
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 208000019116 sleep disease Diseases 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 239000002858 neurotransmitter agent Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000003860 sleep quality Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000218996 Passiflora Species 0.000 description 4
- 244000126002 Ziziphus vulgaris Species 0.000 description 4
- -1 and immune functions Substances 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 239000009627 gardenia yellow Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229960004799 tryptophan Drugs 0.000 description 4
- 206010001497 Agitation Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 244000236658 Paeonia lactiflora Species 0.000 description 3
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 3
- 235000011925 Passiflora alata Nutrition 0.000 description 3
- 235000000370 Passiflora edulis Nutrition 0.000 description 3
- 235000011922 Passiflora incarnata Nutrition 0.000 description 3
- 235000013750 Passiflora mixta Nutrition 0.000 description 3
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 3
- 239000010866 blackwater Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000004622 sleep time Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229940125717 barbiturate Drugs 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000018927 edible plant Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001065207 Bignonia capreolata Species 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000002182 neurohumoral effect Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000003421 short acting drug Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000004617 sleep duration Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000009396 suanzaoren Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种改善睡眠的营养型组合物,包括锌、钙、镁、VB6、VC、L‑色氨酸、VD、VE、酸枣仁、百合、五味子;采用补充微量元素与药食同源植物的睡眠改善成分协同,促进人体的新陈代谢及调节人体微循环的作用,消除烦躁不安,缩短睡前觉醒时间和入睡时间,具有宁心、安魂、养神的功效,进而起到改善睡眠的作用。而上述功能的实现,与各组分的选择,组分间的配伍关系以及用量比优直接的关系,因为中枢神经系统的复杂性,安全性研究至关重要,除了活性研究之外,还必须分析其安全性,如成瘾性、是否存在对学习记忆的不良影响等。将本发明的功能性食品是经过系统的筛选、分析比较而获得上述最佳原料及配比,并不是通过简单叠加获得。The invention discloses a nutritional composition for improving sleep, which comprises zinc, calcium, magnesium, VB6, VC, L-tryptophan, VD, VE, jujube seed, lily, and schisandra; The sleep-improving components of the source plants work together to promote the metabolism of the human body and regulate the microcirculation of the human body, eliminate restlessness, shorten the time of waking up and falling asleep before going to bed, have the effects of calming the mind, calming the soul, and nourishing the mind, and then play a role in improving sleep. effect. The realization of the above functions is directly related to the selection of components, the compatibility relationship between components and the ratio of dosage. Because of the complexity of the central nervous system, safety research is very important. In addition to activity research, it is also necessary Analyze its safety, such as addiction, whether there are adverse effects on learning and memory, etc. The functional food of the present invention is obtained through systematic screening, analysis and comparison to obtain the above-mentioned optimal raw materials and proportions, not through simple superposition.
Description
技术领域technical field
本发明涉及保健食品领域,特别涉及改善睡眠的营养型组合物及其应用。The invention relates to the field of health food, in particular to a nutritional composition for improving sleep and application thereof.
背景技术Background technique
睡眠是高等脊椎动物周期性出现的一种自发的和可逆的静息状态,表现为机体对外界刺激的反应性降低和意识的暂时中断。人的一生大约有1/3的时间是在睡眠中度过的。当人们处于睡眠状态时,可以使大脑和身体得到休息、休整和恢复,有助于人们日常的工作和学习。科学提高睡眠质量,是人们正常工作、学习和生活的保障。睡眠障碍造成了相当一部分人群处于“亚健康”状态。睡眠障碍往往引起人体免疫力低下、精神烦躁,同时还容易引发高血压、神经衰弱、心脑血管意外以及心理疾患等,甚至造成猝死。睡眠障碍给日常工作和生活带来的威胁也是十分可怕的,据统计,30-50%的意外事故由瞌睡引起。据两位美国学者对7000人为期5年半的研究表明,在影响人类寿命的7种因素中,睡眠是重要的一项。睡眠障碍也会导致大量经济损失,美国睡眠障碍研究所一项调查表明,在美国一年因睡眠障碍造成的经济损失达430至560亿美元。常用的治疗睡眠障碍药物包括化学合成类和天然药物,化学合成类药物包括巴比妥类、苯二氮卓类及非苯二氮卓类短效药物,这些药物疗效确切,但成瘾性和反弹性失眠等不良反应严重。我国中草药资源丰富,其中不乏大量可用于治疗失眠,改善睡眠质量的中草药。选用合适的中草药进行搭配,不但可以改善人体内循环,有效的提高人的睡眠质量,而且中草药的毒副作用低、不易产生依赖性。目前,市场上也存在一些用于治疗失眠、提高睡眠质量的中草药,但这些中草药的配方不合理,产品粗糙,睡眠质量提高效果差,而且生产工艺复杂,价格较贵。Sleep is a spontaneous and reversible resting state that occurs periodically in higher vertebrates, manifested as a decrease in the body's response to external stimuli and a temporary interruption of consciousness. About 1/3 of a person's life is spent in sleep. When people are in a sleep state, the brain and body can be rested, rested and recovered, which is helpful for people's daily work and study. Scientifically improving sleep quality is the guarantee for people's normal work, study and life. Sleep disorders have caused a considerable number of people to be in a "sub-healthy" state. Sleep disorders often cause low immunity and mental irritability, and also easily lead to high blood pressure, neurasthenia, cardiovascular and cerebrovascular accidents, and psychological disorders, and even sudden death. The threat that sleep disorder brings to daily work and life is also very terrible. According to statistics, 30-50% of accidents are caused by drowsiness. According to a five-and-a-half-year study by two American scholars on 7,000 people, sleep is an important one among the seven factors that affect human lifespan. Sleep disorders can also cause a large amount of economic losses. According to a survey by the American Institute of Sleep Disorders, the economic losses caused by sleep disorders in the United States amount to 43 to 56 billion U.S. dollars a year. Commonly used drugs for the treatment of sleep disorders include chemosynthetic and natural drugs. Chemosynthetic drugs include barbiturates, benzodiazepines, and non-benzodiazepine short-acting drugs. These drugs have definite curative effects, but they are addictive and Adverse reactions such as rebound insomnia are serious. my country is rich in resources of Chinese herbal medicines, among which there are a large number of Chinese herbal medicines that can be used to treat insomnia and improve sleep quality. Selecting suitable Chinese herbal medicines for combination can not only improve the internal circulation of the human body, effectively improve people's sleep quality, but also the Chinese herbal medicines have low toxic and side effects and are not easy to produce dependence. At present, there are also some Chinese herbal medicines for treating insomnia and improving sleep quality on the market, but the formula of these Chinese herbal medicines is unreasonable, the product is rough, the effect of improving sleep quality is poor, and the production process is complicated, and the price is relatively expensive.
发明内容Contents of the invention
有鉴于此,本发明的目的在于提供一种改善睡眠的营养型组合物及其应用,采用补充微量元素与药食同源植物的睡眠改善成分协同,促进人体的新陈代谢及调节人体微循环的作用,消除烦躁不安,缩短睡前觉醒时间和入睡时间,具有宁心、安魂、养神的功效,进而起到改善睡眠的作用。In view of this, the purpose of the present invention is to provide a nutritional composition for improving sleep and its application, which uses the synergy of supplementing trace elements and sleep-improving ingredients of medicinal and edible plants to promote the metabolism of the human body and regulate the microcirculation of the human body , Eliminate irritability, shorten the time of waking up and falling asleep before going to bed, have the effects of calming the mind, calming the soul, and rejuvenating the mind, and then play a role in improving sleep.
本发明的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present invention comprises the following components:
15~25mg锌、1000~1500mg钙、350~700mg镁、50~100mg VB6、1~2g VC、1~3gL-色氨酸、20~50ug VD、300~500mg VE、10~20g酸枣仁、10~30g百合、10~15g五味子;15~25mg zinc, 1000~1500mg calcium, 350~700mg magnesium, 50~100mg VB6, 1~2g VC, 1~3gL-tryptophan, 20~50ug VD, 300~500mg VE, 10~20g jujube seed, 10 ~30g lily, 10~15g schisandra;
进一步,包括以下组分:Further, the following components are included:
18~25mg锌、1200~1400mg钙、440~650mg镁、60~100mg VB6、1~2g VC、1~3gL-色氨酸、25~45ug VD、380~500mg VE、12~18g酸枣仁、15~25g百合、12~15g五味子。18~25mg zinc, 1200~1400mg calcium, 440~650mg magnesium, 60~100mg VB6, 1~2g VC, 1~3gL-tryptophan, 25~45ug VD, 380~500mg VE, 12~18g jujube seed, 15 ~25g lily, 12~15g schisandra.
进一步,包括以下组分:Further, the following components are included:
20mg锌、1300mg钙、500mg镁、80mg VB6、1.5g VC、2g L-色氨酸、35ug VD、400mgVE、15g酸枣仁、20g百合、13g五味子。20mg zinc, 1300mg calcium, 500mg magnesium, 80mg VB6, 1.5g VC, 2g L-tryptophan, 35ug VD, 400mgVE, 15g jujube seed, 20g lily, 13g schisandra.
进一步,可加入药学、保健品学、食品学上能够接受的载体制成制剂。Furthermore, pharmaceutically, nutraceutical, and food acceptable carriers can be added to make preparations.
本发明的改善睡眠的营养型组合物在制备改善睡眠的药品、保健品、食品上的应用。The application of the sleep-improving nutritional composition of the present invention in the preparation of sleep-improving medicines, health care products and food.
本发明的有益效果:采用补充微量元素与药食同源植物的睡眠改善成分协同,促进人体的新陈代谢及调节人体微循环的作用,消除烦躁不安,缩短睡前觉醒时间和入睡时间,具有宁心、安魂、养神的功效,进而起到改善睡眠的作用。而上述功能的实现,与各组分的选择,组分间的配伍关系以及用量比优直接的关系,因为中枢神经系统的复杂性,安全性研究至关重要,除了活性研究之外,还必须分析其安全性,如成瘾性、是否存在对学习记忆的不良影响等。将本发明的功能性食品是经过系统的筛选、分析比较而获得上述最佳原料及配比,并不是通过简单叠加获得。Beneficial effects of the present invention: supplementing trace elements and synergizing with the sleep-improving ingredients of medicinal and edible plants can promote the metabolism of the human body and regulate the microcirculation of the human body, eliminate restlessness, shorten the time of awakening and falling asleep before going to bed, and have the effect of calming the mind. It has the effect of calming the soul and rejuvenating the mind, and then plays a role in improving sleep. The realization of the above functions is directly related to the selection of components, the compatibility relationship between components and the ratio of dosage. Because of the complexity of the central nervous system, safety research is very important. In addition to activity research, it is also necessary Analyze its safety, such as addiction, whether there are adverse effects on learning and memory, etc. The functional food of the present invention is obtained through systematic screening, analysis and comparison to obtain the above-mentioned optimal raw materials and proportions, not through simple superposition.
锌:作为人体的必需微量元素,锌是机体内许多重要酶的组成成分和(或)激动剂,参与体内多种物质代谢,在抗氧化、抗炎、免疫调节、调节细胞复制和分化、激素分泌和生长发育中起重要作用。睡眠障碍可引起机体行为、认知、情绪、内分泌、神经递质及免疫功能等改变,锌则具有改善上述症状的作用。Zinc: As an essential trace element for the human body, zinc is a component and/or agonist of many important enzymes in the body, participates in the metabolism of various substances in the body, and plays an important role in anti-oxidation, anti-inflammation, immune regulation, regulation of cell replication and differentiation, hormone play an important role in secretion and growth and development. Sleep disorders can cause changes in body behavior, cognition, emotion, endocrine, neurotransmitters, and immune functions, and zinc can improve the above symptoms.
钙:作为人体含量最多的矿物质元素,是构成骨骼的重要组成部分,维持机体的正常生长发育;此外钙参与调节多种激素和神经递质的释放,具有调节肌肉和神经兴奋性的作用。钙缺乏会导致神经肌肉的兴奋性增高,影响睡眠。Calcium: As the most abundant mineral element in the human body, it is an important part of the skeleton and maintains the normal growth and development of the body; in addition, calcium participates in regulating the release of various hormones and neurotransmitters, and has the effect of regulating muscle and nerve excitability. Calcium deficiency can lead to increased neuromuscular excitability and affect sleep.
镁:作为人体的常量元素,是多种酶的激活剂,参与300余种酶促反应,对糖、脂肪、蛋白质的合成与分解、能量代谢、神经、肌肉的兴奋性都具有调节作用。此外,细胞膜电位受镁水平控制,通过这种方式可控制调节睡眠功能的多巴胺、五羟色氨、GABA等神经递质的摄取和释放。Magnesium: As a constant element in the human body, it is an activator of various enzymes, participates in more than 300 kinds of enzymatic reactions, and has a regulating effect on the synthesis and decomposition of sugar, fat, and protein, energy metabolism, and excitability of nerves and muscles. In addition, cell membrane potential is controlled by magnesium levels, which in this way control the uptake and release of neurotransmitters such as dopamine, serotonin, and GABA that regulate sleep function.
VB6:以其活性形式PLP(磷酸吡哆醛)作为许多酶的辅酶,参与神经递质、碳水化合物、神经鞘磷脂、亚铁血红素、脂肪和核酸的代谢,同时参与所有氨基酸代谢。此外,研究显示维生素B6有提高体内抗氧化酶活性、减少脂质过氧化物的作用,从而保护机体免受自由基的损伤,睡眠障碍会导致机体过度氧化应激,其机制可能是通过神经体液反应、能量消耗代谢及自由基的增多、降低机体抗氧化能力、内质网应激等途径诱发机体的氧化应激反应。VC和VE作为体内重要的抗氧化物质,且具有协同作用。VB6: With its active form PLP (pyridoxal phosphate) as the coenzyme of many enzymes, it participates in the metabolism of neurotransmitters, carbohydrates, sphingomyelin, heme, fat and nucleic acids, and participates in all amino acid metabolism. In addition, studies have shown that vitamin B6 can improve the activity of antioxidant enzymes in the body and reduce lipid peroxides, thereby protecting the body from free radical damage. Sleep disorders can lead to excessive oxidative stress in the body. The mechanism may be through neurohumoral Oxidative stress response of the body is induced by the reaction, energy consumption metabolism and increase of free radicals, reduction of the body's antioxidant capacity, and endoplasmic reticulum stress. VC and VE are important antioxidant substances in the body and have a synergistic effect.
VC:作为电子供体具有抗氧化,还是强还原剂,它作为体内维持羟化酶活性所必需的辅助因子,参与体内许多重要物质的合成与代谢,如胶原蛋白、5-羟色胺、去甲肾上腺素等,此外还具有解毒、提高机体抵抗力的作用VC: As an electron donor, it has anti-oxidation and is also a strong reducing agent. It is a cofactor necessary to maintain the activity of hydroxylase in the body, and participates in the synthesis and metabolism of many important substances in the body, such as collagen, 5-hydroxytryptamine, and norepinephrine. In addition, it also has the functions of detoxification and improving the body's resistance
L-色氨酸:色氨酸在人体内可转变为5-羟色胺(5-HT),且是在大脑中唯一能转变生成5-HT的物质。5-HT在脑中可作为神经递质,与神经系统的兴奋与抑制状态密切相关。5-HT降低,可引起睡眠功能障碍。在脑中5-HT还可转变为褪黑素(melatonin,5-甲氧-N-乙酰色胺)。褪黑素具有促进诱导自然睡眠的作用。因此,色氨酸的代谢产物具有平衡心态和提高睡眠质量的作用,可用于抑郁、焦虑、失眠等症。L-tryptophan: Tryptophan can be converted into 5-hydroxytryptamine (5-HT) in the human body, and it is the only substance that can be converted into 5-HT in the brain. 5-HT can be used as a neurotransmitter in the brain, which is closely related to the state of excitation and inhibition of the nervous system. The decrease of 5-HT can cause sleep dysfunction. In the brain, 5-HT can also be converted into melatonin (5-methoxy-N-acetyltryptamine). Melatonin has the effect of promoting natural sleep induction. Therefore, the metabolites of tryptophan can balance the mind and improve sleep quality, and can be used for depression, anxiety, insomnia and other diseases.
VE:主要生理功能是抗氧化作用,是体内最重要的脂溶性抗氧化剂和自由基清除剂。主要对抗生物膜上过氧化所产生的自由基,保护生物膜的结构与功能,使细胞膜维持正常的流动性,其作用机制是与过氧化脂质自由基形成反应性较低且相对稳定的生育酚自由基,后者可在VC或谷胱甘肽的作用下还原称非自由基产物生育酚。VE可调控多种基因表达,如生育酚代谢相关基因、与动脉粥样硬化发生发展相关基因、细胞黏附与抗炎的相关基因、细胞信号转导和细胞周期调节的相关基因等。因此,VE具有除抗氧化作用以外的多种功能,如具有抗炎、维持正常免疫功能和抑制细胞增殖的作用,预防动脉粥样硬化、抗衰老等作用。VE: The main physiological function is anti-oxidation, and it is the most important fat-soluble antioxidant and free radical scavenger in the body. It mainly resists the free radicals produced by peroxidation on the biological membrane, protects the structure and function of the biological membrane, and maintains the normal fluidity of the cell membrane. Phenol free radicals, the latter can be reduced under the action of VC or glutathione to call the non-free radical product tocopherol. VE can regulate the expression of a variety of genes, such as genes related to tocopherol metabolism, genes related to the development of atherosclerosis, genes related to cell adhesion and anti-inflammation, genes related to cell signal transduction and cell cycle regulation, etc. Therefore, VE has multiple functions other than anti-oxidation, such as anti-inflammation, maintaining normal immune function, inhibiting cell proliferation, preventing atherosclerosis, and anti-aging.
酸枣仁:为鼠李科植物酸枣的干燥成熟种子,性味甘平,归心、脾、肝、胆经,具有养肝、宁心、安神、敛汗之功效,是中医治疗失眠常用的养心安神药。酸枣仁主要含有三菇类、黄酮类、脂肪油等生物活性成分。药理实验证实对中枢神经系统起作用的主要是黄酮类、皂苷类化合物,可抑制中枢神经系统,具有镇静作用,其作用机制可能是通过降低脑内单胺类神经递质而实现的。Suanzaoren: It is the dry and mature seed of Ziziphus jujuba, a plant of Rhamnaceae. It is sweet and flat in nature and taste, and has the effects of nourishing the liver, calming the heart, calming the nerves, and suppressing sweat. It is a commonly used nourishing heart in the treatment of insomnia in traditional Chinese medicine. Tranquilizer. Jujube kernel mainly contains three mushrooms, flavonoids, fatty oil and other bioactive components. Pharmacological experiments have confirmed that flavonoids and saponins mainly act on the central nervous system, which can inhibit the central nervous system and have a sedative effect. The mechanism of action may be achieved by reducing monoamine neurotransmitters in the brain.
百合:味甘、微苦,性微寒,归心、肺经,具有养阴润肺、清心安神之功。用于治疗阴虚久咳、虚烦、失眠等症。主要含有多糖、皂甙、生物碱、磷脂等多种化合物,现代药理研究显示百合中的百合苷具有镇静和催眠的作用,百合可明显延长戊巴比妥钠睡眠时间,并使域下量戊巴比妥钠睡眠率显著提高。此外,百合还具有增强机体抵抗力、抗癌等功能。Lily: sweet, slightly bitter, slightly cold in nature, homecoming, lung meridian, has the power of nourishing yin and moistening lung, clearing heart and calming nerves. It is used to treat chronic cough due to yin deficiency, restlessness due to deficiency, and insomnia. It mainly contains polysaccharides, saponins, alkaloids, phospholipids and other compounds. Modern pharmacological studies have shown that lilyin in lily has sedative and hypnotic effects. The rate of sleep was significantly improved with sodium-bital. In addition, lily also has functions such as enhancing the body's resistance and anti-cancer.
五味子:性温,味酸、甘,具有收敛固涩,益气生津,补肾宁心之功效。常用于治疗久咳虚喘、梦遗滑精、遗尿尿频、久泻不止、自汗、盗汗、神经衰弱、肝炎等疾病。五味子还含有有木脂素、多糖和挥发油等生物活性成分,现代药理研究证实,五味子提取物和五味子醇甲均能减少小鼠自主活动,延长巴比妥诱导小鼠睡眠持续时间五味子多糖和木脂素类成分具有显著的镇静和改善睡眠作用。Schisandra chinensis: warm in nature, sour and sweet in taste, has the effects of astringing and astringent, nourishing qi and promoting body fluid, nourishing kidney and calming heart. It is often used to treat diseases such as chronic cough, shortness of breath, nocturnal emission, enuresis, frequent urination, chronic diarrhea, spontaneous perspiration, night sweats, neurasthenia, hepatitis, etc. Schisandra chinensis also contains biologically active components such as lignans, polysaccharides and volatile oils. Modern pharmacological studies have confirmed that both schisandra chinensis extracts and schisandrin A can reduce the autonomous activity of mice and prolong the sleep duration of mice induced by barbiturates. The lipid components have significant sedative and sleep-improving effects.
还可加入茯神,协同戊巴比妥钠对中枢系统发挥抑制作用,可加入西番莲花改善焦虑,还可加入夜交藤、黑水缬草改善睡眠作用的机制与脑内神经递质GABA,5-HT的含量;加入栀子黄色素、二十二碳六烯酸-磷脂(DHA-PC)、白芍等改善睡眠,上述组分的添加量均为2-4g。Fushen can also be added to cooperate with pentobarbital sodium to exert an inhibitory effect on the central system, passion flower can be added to improve anxiety, and night vine and black water valerian can also be added to improve sleep. , the content of 5-HT; add gardenia yellow pigment, docosahexaenoic acid-phospholipid (DHA-PC), white peony root, etc. to improve sleep, and the addition amount of the above components is 2-4g.
具体实施方式detailed description
实施例一Embodiment one
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
15mg锌、1000mg钙、350mg镁、50mg VB6、1g VC、1g L-色氨酸、20ug VD、300mg VE、10g酸枣仁、10g百合、10g五味子。15mg zinc, 1000mg calcium, 350mg magnesium, 50mg VB6, 1g VC, 1g L-tryptophan, 20ug VD, 300mg VE, 10g jujube seed, 10g lily, 10g schisandra.
实施例二Embodiment two
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
25mg锌、1500mg钙、700mg镁、100mg VB6、2g VC、3g L-色氨酸、50ug VD、500mg VE、20g酸枣仁、30g百合、15g五味子。25mg zinc, 1500mg calcium, 700mg magnesium, 100mg VB6, 2g VC, 3g L-tryptophan, 50ug VD, 500mg VE, 20g jujube seed, 30g lily, 15g schisandra.
实施例三Embodiment Three
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
18mg锌、1200mg钙、440mg镁、60mg VB6、1g VC、1g L-色氨酸、25ug VD、380mg VE、12g酸枣仁、15g百合、12g五味子。18mg zinc, 1200mg calcium, 440mg magnesium, 60mg VB6, 1g VC, 1g L-tryptophan, 25ug VD, 380mg VE, 12g jujube seed, 15g lily, 12g schisandra.
实施例四Embodiment four
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
25mg锌、1400mg钙、650mg镁、100mg VB6、2g VC、3g L-色氨酸、45ug VD、500mg VE、18g酸枣仁、25g百合、15g五味子。25mg zinc, 1400mg calcium, 650mg magnesium, 100mg VB6, 2g VC, 3g L-tryptophan, 45ug VD, 500mg VE, 18g jujube seed, 25g lily, 15g schisandra.
实施例五Embodiment five
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
18mg锌、1400mg钙、440mg镁、100mg VB6、1g VC、3g L-色氨酸、25ug VD、500mg VE、12g酸枣仁、25g百合、12g五味子。18mg zinc, 1400mg calcium, 440mg magnesium, 100mg VB6, 1g VC, 3g L-tryptophan, 25ug VD, 500mg VE, 12g jujube seed, 25g lily, 12g schisandra.
实施例六Embodiment six
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
20mg锌、1300mg钙、500mg镁、80mg VB6、1.5g VC、2g L-色氨酸、35ug VD、400mgVE、15g酸枣仁、20g百合、13g五味子。20mg zinc, 1300mg calcium, 500mg magnesium, 80mg VB6, 1.5g VC, 2g L-tryptophan, 35ug VD, 400mgVE, 15g jujube seed, 20g lily, 13g schisandra.
实施例七Embodiment seven
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
18mg锌、1200mg钙、650mg镁、100mg VB6、1g VC、1g L-色氨酸、45ug VD、500mg VE、12g酸枣仁、15g百合、15g五味子、2g茯神、2g西番莲花改善焦虑、2g夜交藤、2g黑水缬草、2g栀子黄色素、2g二十二碳六烯酸-磷脂(DHA-PC)、2g白芍。18mg Zinc, 1200mg Calcium, 650mg Magnesium, 100mg VB6, 1g VC, 1g L-Tryptophan, 45ug VD, 500mg VE, 12g Jujube Seed, 15g Lily, 15g Schisandra, 2g Fushen, 2g Passion Flower Improve Anxiety, 2g Night cross vine, 2g black water valerian, 2g gardenia yellow pigment, 2g docosahexaenoic acid-phospholipid (DHA-PC), 2g white peony root.
实施例八Embodiment Eight
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
25mg锌、1000mg钙、700mg镁、50mg VB6、2g VC、1g L-色氨酸、50ug VD、300mg VE、20g酸枣仁、10g百合、15g五味子、2g茯神、4g西番莲花改善焦虑、4g栀子黄色素、4g二十二碳六烯酸-磷脂(DHA-PC)。25mg Zinc, 1000mg Calcium, 700mg Magnesium, 50mg VB6, 2g VC, 1g L-Tryptophan, 50ug VD, 300mg VE, 20g Jujube Seed, 10g Lily, 15g Schisandra, 2g Fushen, 4g Passiflora Improve Anxiety, 4g Gardenia yellow pigment, 4g docosahexaenoic acid-phospholipid (DHA-PC).
实施例九Embodiment nine
本实施例的改善睡眠的营养型组合物,包括以下组分:The nutritional composition for improving sleep of the present embodiment comprises the following components:
25mg锌、1500mg钙、700mg镁、50mg VB6、1g VC、1g L-色氨酸、50ug VD、300mg VE、20g酸枣仁、10g百合、15g五味子、3g茯神、2g西番莲花、、黑水3g栀子黄色素、3g白芍。25mg zinc, 1500mg calcium, 700mg magnesium, 50mg VB6, 1g VC, 1g L-tryptophan, 50ug VD, 300mg VE, 20g jujube seed, 10g lily, 15g schisandra, 3g Fushen, 2g passion flower, black water 3g gardenia yellow pigment, 3g white peony.
将上述实施例的用改善睡眠的营养型组合物加入医学或食品学或保健品学上能够接受的载体制成制剂,可以通过添加本领域使用的任何辅料制备成适合的剂型。所述的辅料包括但不限于崩解剂、填充剂、润滑剂、润湿剂、增溶剂、助溶剂、乳化剂、着色剂、黏合剂、渗透压、调节剂、稳定剂、助流剂、矫味剂、防腐剂、助悬剂、包衣材料、芳香剂、抗黏着剂、抗氧剂、抗氧增效剂、鳌合剂、渗透促进剂、pH调节剂、增塑剂、表面活性剂、发泡剂、消泡剂、增稠剂、包合剂、保湿剂、吸收剂、稀释剂、絮凝剂与反絮凝剂、助滤剂等。Add the sleep-improving nutritional composition of the above examples to a medically or food- or health-care acceptable carrier to make a preparation, which can be prepared into a suitable dosage form by adding any excipients used in this field. The auxiliary materials include but are not limited to disintegrants, fillers, lubricants, wetting agents, solubilizers, cosolvents, emulsifiers, colorants, adhesives, osmotic pressure, regulators, stabilizers, glidants, Flavoring agent, preservative, suspending agent, coating material, fragrance, anti-adhesive agent, antioxidant, antioxidant synergist, chelating agent, penetration enhancer, pH regulator, plasticizer, surfactant , foaming agent, defoaming agent, thickener, inclusion agent, humectant, absorbent, diluent, flocculant and deflocculant, filter aid, etc.
将用于改善睡眠的营养型组合物在制备调改善睡眠的食品、保健品、药物中的应用。Application of the nutritional composition for improving sleep in the preparation of food, health products and medicines for improving sleep.
实验例:Experimental example:
选取了患有失眠的100人为例,年龄范围14-62岁,男45人,女55人,疗程为2个月。每人每天服用1次采用本发明实施例1的产品。效果判断标准为:100 people suffering from insomnia were selected as an example, the age range was 14-62 years old, 45 were male and 55 were female, and the course of treatment was 2 months. Each person takes the product of Example 1 of the present invention once a day. The effect judgment standard is:
显效:睡眠时间恢复正常,或夜间睡眠时间在6小时以上,睡眠深沉,醒后精力充沛;Significant effect: the sleep time returns to normal, or the sleep time at night is more than 6 hours, the sleep is deep, and the energy is energetic after waking up;
有效:睡眠明显好转或减轻,睡眠时间增加3小时以上,睡眠深度增加;Effective: the sleep is obviously improved or reduced, the sleep time is increased by more than 3 hours, and the sleep depth is increased;
无效:失眠状况无任何改善。Invalid: no improvement in insomnia.
通过两个月的跟踪调查,得出以下表1所列数据:Through the two-month follow-up investigation, the data listed in Table 1 below are obtained:
本发明的效果Effect of the present invention
由以上数据,本发明改善睡眠的营养型组合物的有效率达95%。According to the above data, the effective rate of the nutritional composition for improving sleep of the present invention reaches 95%.
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention without limitation. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solutions of the present invention can be carried out Modifications or equivalent replacements without departing from the spirit and scope of the technical solution of the present invention shall be covered by the claims of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610493354.3A CN106036877A (en) | 2016-06-29 | 2016-06-29 | Nutritional compound for improving sleep and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610493354.3A CN106036877A (en) | 2016-06-29 | 2016-06-29 | Nutritional compound for improving sleep and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106036877A true CN106036877A (en) | 2016-10-26 |
Family
ID=57167040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610493354.3A Pending CN106036877A (en) | 2016-06-29 | 2016-06-29 | Nutritional compound for improving sleep and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106036877A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106723021A (en) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | A kind of functional food for improving the health care of sleep |
CN111508585A (en) * | 2020-04-24 | 2020-08-07 | 珠海格力电器股份有限公司 | Diet recommendation method, device, storage medium and system |
WO2021227796A1 (en) * | 2020-05-11 | 2021-11-18 | 浙江养生堂天然药物研究所有限公司 | Drinking water for improving sleep quality |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101480481A (en) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | Compound recipe for improving sleeping as well as preparation method and application |
CN102793165A (en) * | 2012-07-20 | 2012-11-28 | 惠州市鑫福来实业发展有限公司 | Health care deep sleep capsule for improving sleep quality and preparation method thereof |
CN103054044A (en) * | 2012-12-26 | 2013-04-24 | 北京康比特体育科技股份有限公司 | Sleep-improving health food composition |
CN104738624A (en) * | 2015-03-17 | 2015-07-01 | 鄢明亮 | Nutritional health-care food for neurasthenia, amnesia and insomnia |
-
2016
- 2016-06-29 CN CN201610493354.3A patent/CN106036877A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101480481A (en) * | 2008-01-07 | 2009-07-15 | 南京万舜源生物科技有限公司 | Compound recipe for improving sleeping as well as preparation method and application |
CN102793165A (en) * | 2012-07-20 | 2012-11-28 | 惠州市鑫福来实业发展有限公司 | Health care deep sleep capsule for improving sleep quality and preparation method thereof |
CN103054044A (en) * | 2012-12-26 | 2013-04-24 | 北京康比特体育科技股份有限公司 | Sleep-improving health food composition |
CN104738624A (en) * | 2015-03-17 | 2015-07-01 | 鄢明亮 | Nutritional health-care food for neurasthenia, amnesia and insomnia |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106723021A (en) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | A kind of functional food for improving the health care of sleep |
CN111508585A (en) * | 2020-04-24 | 2020-08-07 | 珠海格力电器股份有限公司 | Diet recommendation method, device, storage medium and system |
CN111508585B (en) * | 2020-04-24 | 2022-07-15 | 珠海格力电器股份有限公司 | Diet recommendation method, device, storage medium and system |
WO2021227796A1 (en) * | 2020-05-11 | 2021-11-18 | 浙江养生堂天然药物研究所有限公司 | Drinking water for improving sleep quality |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210220422A1 (en) | Dietary supplement compositions and methods | |
CN103784611B (en) | It is a kind of that there is improvement sleep to help to alleviate composition and its application of pressure | |
Tabassum et al. | Natural cognitive enhancers | |
CN107126485B (en) | Traditional Chinese medicine composition for assisting in improving sleep and preparation method and application thereof | |
CN109106738A (en) | A kind of nervonic acid composition and its application in neuroprotection | |
CN109316528B (en) | Medicine for treating male erectile dysfunction and preparation method thereof | |
TW200913988A (en) | Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient | |
Joshi Pranav | A review on natural memory enhancers (Nootropics) | |
WO2014175773A1 (en) | A formula for restoring normal sleep and biological rhythms | |
CN106376917A (en) | Health food or drink formula for regulating emotions from multiple aspects | |
CN106036877A (en) | Nutritional compound for improving sleep and application thereof | |
CN104873745A (en) | Traditional Chinese medicine composition for treating insomnia and preparation method | |
CN107028169A (en) | A kind of composition for improving memory and preparation method thereof | |
US20100015259A1 (en) | Composition and method for improving human concentration, memory and other cognitive brain | |
US20190209491A1 (en) | Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache | |
CN108743891A (en) | A kind of pure natural promoting blood circulation, removing blood stasis and relieving pain hydrogen-rich pharmaceutical composition and the preparation method and application thereof | |
CN105249440A (en) | Donkey-hide gelatin cake | |
CN112089760A (en) | Healthy wine based on ethanol dehydrogenase inhibition | |
CN115350260B (en) | Daily care biological agent with sleep-aiding function for skin and preparation method thereof | |
JP2000143546A (en) | Suppressant for oxidative decomposition of melatonin | |
US6531162B1 (en) | Adrenergically-mediated weight loss product | |
JP4904795B2 (en) | Fatigue improver composition | |
CN104694315A (en) | Anti-ageing wine and preparing method thereof | |
KR20160058237A (en) | Health Food Composition with Anti-stress and Relaxing Effect | |
CN111686236B (en) | Capsule for dispelling effects of alcohol, protecting liver and protecting brain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |
|
RJ01 | Rejection of invention patent application after publication |